A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR. - sprookjes - yvandenbroek - TriplyDB

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

http://www.wikidata.org/entity/Q34312127

about

Thrombospondin-1 type 1 repeats in a model of inflammatory bowel disease: transcript profile and therapeutic effects Protein Kinase D1 Signaling in Angiogenic Gene Expression and VEGF-Mediated Angiogenesis Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling.Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer.Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.The thrombospondins.Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas.Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.Original insights on thrombospondin-1-related antireceptor strategies in cancer.Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways.Therapies using anti-angiogenic peptide mimetics of thrombospondin-1.Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas.Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level.Thrombospondins function as regulators of angiogenesis.Integration of pro- and anti-angiogenic signals by endothelial cells.Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.Calcium-induced conformational changes of Thrombospondin-1 signature domain: implications for vascular disease.Alternative transcription of a shorter, non-anti-angiogenic thrombospondin-2 variant in cancer-associated blood vessels.Apigenin Inhibits UVB-Induced Skin Carcinogenesis: The Role of Thrombospondin-1 as an Anti-Inflammatory Factor

P2860

Q21561021-EE262731-2FC3-48FA-BECC-F0A38E0A7119 Q26747243-91FE1952-A445-4CBF-BB0F-AF5E7E382944 Q33618393-84F50343-DBE8-437B-A742-5AC404E29F9D Q34153021-5C918F97-F5E9-4A47-A684-DE7A1067D208 Q35037444-F85B6FE4-3AA8-4302-BADC-CDC101960ECE Q35039333-3A058A2A-075A-40BE-B62E-A57F574B3F40 Q35230013-12F8B1A8-F8E5-49D1-A6E8-AA0689C60084 Q35653261-A628BBE7-876B-4070-ADEC-7C6A2DAD7E08 Q35902676-7CD73C5C-300E-49F4-BF11-A078D5096103 Q36221374-30A5228D-BDA0-46A0-BDC5-09B532E799D2 Q36578825-4D6F3F29-FF67-432C-AF86-331C7BAA3468 Q36695971-279DCC5E-633A-4A2F-B131-9B0E0F44148B Q36940630-635F3E1A-B056-4C7D-B8C8-93E20AF9ED90 Q36979082-1523DD76-7123-40C3-B147-DD500DFADD4E Q37680195-11A7196F-DB7B-45AF-9BE2-846887E1D062 Q37963916-90F0BEE4-6BEB-4FE5-86A5-F6D585C14A61 Q38938230-54631515-9408-43FC-B595-573287FCB4AB Q42560909-D53763A8-36BF-4EF3-8719-341F162301C1 Q42643939-26A13614-E544-42E1-B077-6CECED64030E Q47267571-EE1ACC08-8295-4C48-847F-BD6830B132CB Q50019794-E669EF43-0879-4081-8E58-64B0886C6DE3 Q51218942-3612C2C9-3B66-49D8-9ED9-68A8AB549507 Q52691490-1AE1FFE0-2A9B-47BA-9FAB-B8346EF35B3F Q58777810-411CC73C-0448-4C5C-80C5-2D0D1A28E4EF

P2860

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

http://www.wikidata.org/entity/Q34312127

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

@ast

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

@en

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

@nl

type

label

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

@ast

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

@en

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

@nl

prefLabel

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

@ast

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

@en

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

@nl

P1433

Q34312127-55C3AD69-7028-47E5-A9D8-C8BCF7716B9F

P1476

Q34312127-98BA8848-3B2E-4CBB-B70F-72BC870C7DE8

P2093

Q34312127-037543ED-294A-4698-BA75-B579A90D8398

Q34312127-174F41F9-6C3E-41BF-9462-03EB57BB467B

Q34312127-2A8B36D4-E435-4B3E-BECF-60CA33DF1E7B

Q34312127-679B166C-E971-4577-8CD9-3C7270B49F26

Q34312127-8E9B243D-DE31-4E7C-9D62-B2DC546220B6

Q34312127-92EBE456-78CB-41C3-ABA0-7BC87B90465B

Q34312127-B106464F-0C43-4103-BBB8-BC31B4F56F72

Q34312127-DC8831F0-E632-4C14-9310-ACD2716267DC

Q34312127-ECD2F3C4-ECE7-46A4-BA00-6B3AE885B42E

Q34312127-FA05D3D0-2748-4F8D-8B84-027DBCF3D91C

P2860

Q34312127-0045977C-4D21-4572-8944-A1FB91FAD086

Q34312127-01B17DFB-0739-41A7-A9C1-325A597547A4

Q34312127-0CEC4CE4-F0A5-42A8-8B2A-EA21754E88C1

Q34312127-0EB4AFA7-E827-40BB-AEAA-81C7D1AE25C4

Q34312127-0EB6D696-0C51-44C3-8BEB-7BCDD5F7367B

Q34312127-149715E9-D5BF-4B40-AB1E-DEF5A2D6AE57

Q34312127-25DEFACD-F94D-4419-AA6A-A9669F2E3A1E

Q34312127-27F2EC87-19C2-4878-914A-2D7B209CD0FD

Q34312127-292E0E14-7937-4119-A8BC-A3FFF3993B0F

Q34312127-33411D47-A95E-46D5-9B9F-D2E02DE03ED8

P304

Q34312127-8472BBD5-C668-49C2-A931-D187F7F05EC0

P31

Q34312127-217E9A72-F67D-4B32-8ACC-72F15FCEE9A8

P356

Q34312127-20644C27-A43D-4F24-9821-DEAE63503C92

P407

Q34312127-5AEC7490-7838-493A-944E-3D2C0A4BC125

P433

Q34312127-BB6B029C-9930-4BA3-A786-436EB20D61E0

P478

Q34312127-5EED9387-314F-48DF-81B3-65F8102AEAD7

P50

Q34312127-C25865F3-9A80-4C36-8AB4-446090ED2933

P577

Q34312127-81B5D1BF-7CF6-495D-AE4F-50C9D8963F2F

P698

Q34312127-7E3142B0-C7EB-47AA-9600-D72CB0B9DB25

P921

Q34312127-7DD05325-718D-4DB3-A5FC-78CC87C4909F

P932

Q34312127-1BB3F1F2-ACCD-480E-8A26-889AA47D2818

P356

0008-5472.CAN-08-2940

P1433

Cancer Research

P1476

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR

@en

P2093

Jack Lawler

http://www.w3.org/2001/XMLSchema#string

Keli Song

http://www.w3.org/2001/XMLSchema#string

Mark Duquette

http://www.w3.org/2001/XMLSchema#string

Min Ye

http://www.w3.org/2001/XMLSchema#string

Nordine Benhaga

http://www.w3.org/2001/XMLSchema#string

Robin Humphreys

http://www.w3.org/2001/XMLSchema#string

Roya Khosravi-Far

http://www.w3.org/2001/XMLSchema#string

Sareh Parangi

http://www.w3.org/2001/XMLSchema#string

Taiguang Jin

http://www.w3.org/2001/XMLSchema#string

Xuefeng Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

The complexity of TNF-related apoptosis-inducing ligand

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor

Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells

Cell death: critical control points

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

Two CD95 (APO-1/Fas) signaling pathways

SH3 domains direct cellular localization of signaling molecules.

Death receptor signals to mitochondria.

P304

3856-3865

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-2940

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19366809

http://www.w3.org/2001/XMLSchema#string

P921

P932

2981788

http://www.w3.org/2001/XMLSchema#string